SPARC and pancreatic ductal adenocarcinoma: These differential effects may also be linked to diverging roles of SPARC in the tumor as compared to the stroma, as stromal expression but not tumor expression has been linked to poor patient outcomes in pancreatic ductal adenocarcinoma [64].